Cargando…

Micro-Raman spectroscopy study of blood samples from myocardial infarction patients

Acute myocardial infarction (MI) is found to be a major causative factor for global mortality and morbidity. This situation demands necessity of developing efficient and rapid diagnostic tools to detect acute MI. Raman spectroscopy is a non-destructive optical diagnostic technique, which has high po...

Descripción completa

Detalles Bibliográficos
Autores principales: John, Reena V., Devasia, Tom, N., Mithun, Lukose, Jijo, Chidangil, Santhosh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708773/
https://www.ncbi.nlm.nih.gov/pubmed/35821543
http://dx.doi.org/10.1007/s10103-022-03604-1
_version_ 1784841012170981376
author John, Reena V.
Devasia, Tom
N., Mithun
Lukose, Jijo
Chidangil, Santhosh
author_facet John, Reena V.
Devasia, Tom
N., Mithun
Lukose, Jijo
Chidangil, Santhosh
author_sort John, Reena V.
collection PubMed
description Acute myocardial infarction (MI) is found to be a major causative factor for global mortality and morbidity. This situation demands necessity of developing efficient and rapid diagnostic tools to detect acute MI. Raman spectroscopy is a non-destructive optical diagnostic technique, which has high potential in probing biochemical changes in clinical samples during initiation and progress of diseases. In this work, blood was taken as the sample to examine inflammation in acute MI patients using Raman spectroscopy. Ratio of Raman peak intensities that corresponds to phenylalanine (1000 cm(−1)) and tyrosine (825 cm(−1)) can facilitate indirect information about tetrahydrobiopterin (BH4) availability, which can indicate inflammatory status in patients. This ratio obtained was higher for MI patients in comparison with control subjects. The decrease in phenylalanine and tyrosine ratio (Phe-Tyr ratio) is attributed to the prognosis of standard of care (medications like antiplatelets including aspirin, statin and revascularisation) leading to inflammation reduction. Phe-Tyr ratio estimated from the Raman spectra of blood can be exploited as a reliable method to probe inflammation due to MI. The method is highly objective, require only microliters of sample and minimal sample preparation, signifying its clinical utility.
format Online
Article
Text
id pubmed-9708773
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer London
record_format MEDLINE/PubMed
spelling pubmed-97087732022-12-01 Micro-Raman spectroscopy study of blood samples from myocardial infarction patients John, Reena V. Devasia, Tom N., Mithun Lukose, Jijo Chidangil, Santhosh Lasers Med Sci Original Article Acute myocardial infarction (MI) is found to be a major causative factor for global mortality and morbidity. This situation demands necessity of developing efficient and rapid diagnostic tools to detect acute MI. Raman spectroscopy is a non-destructive optical diagnostic technique, which has high potential in probing biochemical changes in clinical samples during initiation and progress of diseases. In this work, blood was taken as the sample to examine inflammation in acute MI patients using Raman spectroscopy. Ratio of Raman peak intensities that corresponds to phenylalanine (1000 cm(−1)) and tyrosine (825 cm(−1)) can facilitate indirect information about tetrahydrobiopterin (BH4) availability, which can indicate inflammatory status in patients. This ratio obtained was higher for MI patients in comparison with control subjects. The decrease in phenylalanine and tyrosine ratio (Phe-Tyr ratio) is attributed to the prognosis of standard of care (medications like antiplatelets including aspirin, statin and revascularisation) leading to inflammation reduction. Phe-Tyr ratio estimated from the Raman spectra of blood can be exploited as a reliable method to probe inflammation due to MI. The method is highly objective, require only microliters of sample and minimal sample preparation, signifying its clinical utility. Springer London 2022-07-12 2022 /pmc/articles/PMC9708773/ /pubmed/35821543 http://dx.doi.org/10.1007/s10103-022-03604-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Article
John, Reena V.
Devasia, Tom
N., Mithun
Lukose, Jijo
Chidangil, Santhosh
Micro-Raman spectroscopy study of blood samples from myocardial infarction patients
title Micro-Raman spectroscopy study of blood samples from myocardial infarction patients
title_full Micro-Raman spectroscopy study of blood samples from myocardial infarction patients
title_fullStr Micro-Raman spectroscopy study of blood samples from myocardial infarction patients
title_full_unstemmed Micro-Raman spectroscopy study of blood samples from myocardial infarction patients
title_short Micro-Raman spectroscopy study of blood samples from myocardial infarction patients
title_sort micro-raman spectroscopy study of blood samples from myocardial infarction patients
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708773/
https://www.ncbi.nlm.nih.gov/pubmed/35821543
http://dx.doi.org/10.1007/s10103-022-03604-1
work_keys_str_mv AT johnreenav microramanspectroscopystudyofbloodsamplesfrommyocardialinfarctionpatients
AT devasiatom microramanspectroscopystudyofbloodsamplesfrommyocardialinfarctionpatients
AT nmithun microramanspectroscopystudyofbloodsamplesfrommyocardialinfarctionpatients
AT lukosejijo microramanspectroscopystudyofbloodsamplesfrommyocardialinfarctionpatients
AT chidangilsanthosh microramanspectroscopystudyofbloodsamplesfrommyocardialinfarctionpatients